Optoceutics ApS

CVR39769689

Core data

Name
Optoceutics ApS
Address
Nørrebrogade 45C 4 tv, 2200, København N
Founded
Aug 8, 2018
Employees (CVR)
5
Locations (P-units)
1View locations
Website
https://optoceutics.com/
Facebook
OptoCeutics
Instagram
@optoceutics
LinkedIn
optoceutics
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of Optoceutics ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

OptoCeutics is a neurotechnology company focused on light-based brain technology and cognitive wellness. Its EVY product delivers 40Hz light and optional sound stimulation as a general wellness product for people and families living with Alzheimer’s, dementia, and Mild Cognitive Impairment.

The company develops and provides EVY LIGHT®, a non-invasive 40Hz light stimulation device, together with the optional EVY INSIGHT app and 40Hz sound therapy. The products are intended to support healthy brain activity and general wellness, but are not medical devices and are not intended to diagnose, treat, cure, or prevent disease.

Company's own description on virk.dk

The company's primary activities has been at the forefront of medical research and innovation since 2018, driven by a vision to address neurological and psychiatric diseases. Our primary focus is on targeting electrical signaling deficits in the brain, with the end goal of developing treatments for conditions such as Alzheimer's disease and dementia.

Products & services

EVY LIGHT® device · EVY INSIGHT app · 40Hz light stimulation · 40Hz sound therapy · Customized brightness control · Daily progress tracking and usage history insights

Industries

Neurotechnology · Brain health · General wellness products

Customer types

Families and caregivers of people living with Alzheimer’s or dementia · People living with Mild Cognitive Impairment (MCI) · Senior living and memory care communities

Financials

Company financials
Reporting period
2025DKK
Gross profit
-2,585,556
Operating profit
-8,440,215
Profit before tax
-9,205,326
Net income
-8,736,152
Total assets
43,577,521
Equity
32,320,160
Avg. employees
7
2019–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
2345****Show full
m**@optoceutics.comShow full

From optoceutics.com

Main
in**@optoceutics.comShow full
User Manual
+1 (209) 213-****Show full
+1 (415) 881-****Show full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Jes BroengRoles
Board
TitlesFORMAND
Kaare Agerholm DanielsenRoles
Board
TitlesBESTYRELSESMEDLEM
Marcus Schultz CarstensenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR

Auditor

inforevision statsautoriseret revisionsaktieselskabAuditorMichael Dam-JohansenRoleState Authorised Public AccountantFromJun 30, 2026
Ownership33.33–49.99 %Voting rights33.33 %FromJul 29, 2026

Unknown Other Participant

Ownership15–19.99 %Voting rights15 %FromNov 7, 2022
Ownership10–14.99 %Voting rights10 %FromDec 30, 2024

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromDec 29, 2023
Ownership5–9.99 %Voting rights5 %FromJan 31, 2020

Ultimate owners

🇺🇸Ngoc Mai Thi Nguyen
Ownership through
Direct
15–19.99 %
Kaare Agerholm Danielsen
Ownership through
11.1–25 %
Marcus Schultz Carstensen
Ownership through
10–14.99 %
Dorte Frøland Danielsen
Ownership through
8.33–16.66 %
Holger Rubæk Danielsen
Ownership through
8.33–16.66 %
Rasmus Just
Ownership through
5–9.99 %
🇺🇸Sebastian Scripps
Ownership through
Direct
5–9.99 %

Official sources